Bites by tarantulas (Theraphosidae, Mygalomorphae) in humans can result in mild clinical manifestations such as local pain, erythema, and edema. Vitalius dubius is a medium-sized, nonaggressive theraphosid found in southeastern Brazil. In this work, we investigated the mediators involved in the plasma extravasation caused by V. dubius venom in rats. The venom caused dose-dependent (0.1-100 mg/site) edema in rat dorsal skin. This edema was significantly inhibited by butyl]benzamide) (SR48968, a neurokinin NK 2 receptor antagonist) had no effect on the venom-induced increase in vascular permeability. In rat hind paws, the venom-induced edema was attenuated by ketoprofen (a nonselective COX inhibitor) administered 15 minutes postvenom. Preincubation of venom with commercial antiarachnid antivenom attenuated the venom-induced edema. These results suggest that the enhanced vascular permeability evoked by V. dubius venom involves serotonin, COX products, neurokinin NK 1 receptors, and nitric oxide formation. The attenuation of hind paw edema by ketoprofen suggests that COX inhibitors could be useful in treating the local inflammatory response to bites by these spiders.
Introduction
Spiders of the family Theraphosidae (suborder Mygalomorphae), popularly known as tarantulas, have a widespread distribution throughout the tropics. The venoms of these spiders contain a variety of toxins that target primarily ion channels (Escoubas, 2006; Estrada et al., 2007; Herzig et al., 2011) . Despite their large size and intimidating appearance, most theraphosids show low aggressivity, and this has led to their popularity as pets, particularly in North America and Europe. Although theraphosids have potentially large venom yields compared with other spiders, the clinical manifestations of human envenoming by these spiders are generally limited to local effects that include varying degrees of pain, erythema, and edema (Lucas et al., 1994; Isbister et al., 2003) ; however, prolonged muscle cramps have been reported after envenoming by Poecilotheria regalis (Indian ornamental tree spider) (Fuchs et al., 2014) . Many theraphosid species are also capable of releasing urticating hairs that cause an allergic reaction in sensitive individuals (Battisti et al., 2011) . Experimental studies in vertebrates (Bücherl, 1971; Bettini and Brignoli, 1978; Atkinson, 1993) , together with the findings of clinical reports of envenoming in humans, indicate that the effects of theraphosid venoms are more severe in domestic animals and may include death (Robinson and Griffin, 1985; Raven, 2000; Isbister et al., 2003) .
The theraphosid genus Vitalius contains at least nine species found predominantly in southeastern Brazil, with Vitalius dubius occurring in the southern part of the Brazilian state of Minas Gerais and in the state of São Paulo (Bertani, 2001) . We have previously reported on the venom gland structure (Rocha-e-Silva et al., 2009a) and general venom composition (Rocha-e-Silva et al., 2009b) of V. dubius. We have also isolated a nicotinic receptor antagonist (Rocha-e-Silva et al., 2013) and hyaluronidase (Sutti et al., 2014 ) from this venom. In this work, we have extended our investigation of V. dubius venom by examining its ability to increase vascular permeability in rat dorsal skin and hind paw. We also assessed some of the mediators involved and examined the ability of postvenom treatment with ketoprofen, a nonselective cyclooxygenase (COX) inhibitor, to attenuate venom-induced hind paw edema.
Materials and Methods
Animals. Male Wistar-Hanover rats (200-250 g) were obtained from the Multidisciplinary Center for Biologic Investigation (CEMIB/ Universidade Estadual de Campinas) and were housed 5/cage at 23°C on a 12-hour light/dark cycle, with free access to food and water. The experimental protocols were approved by an institutional Committee for Ethics in Animal Use (CEUA/Universidade Estadual de Campinas, protocol 1228-1 and CEUA/Santa Casa, protocol 001/13), and the general ethical guidelines for animal use established by the Brazilian Society of Laboratory Animal Science (SBCAL) and EC Directive 86/ 609/EEC for animal experiments were followed.
Drugs. Bradykinin, cyproheptadine, compound 48/80, histamine, indomethacin, mepyramine, N v -nitro-L-arginine methyl ester (L-NAME), and Evan's blue dye were purchased from Sigma-Aldrich (St. Louis, MO). Ketoprofen [(RS)2-(3-benzoylphenyl)-propionic acid] was purchased from Sanofi-Aventis Farmacêutica (Susano, SP, Brazil). Venoms and Antivenom. The venoms of V. dubius (Rocha-eSilva et al., 2009b), Phoneutria nigriventer (wandering spider), and Tityus serrulatus (yellow scorpion) were obtained by electrical stimulation of specimens of both sexes. Antiarachnid antivenom produced by the Instituto Butantan (São Paulo, SP, Brazil) and obtained by immunizing horses with a pool of spider (P. nigriventer and Loxosceles gaucho) and scorpion (Tityus serrulatus) venoms (Cardoso et al., 2003) was provided by the Poison Control Center of the university teaching hospital at Universidade Estadual de Campinas.
Rat Dorsal Skin Edema. Rats were anesthetized with thiopental (60 mg/kg, i.p.) and maintained anesthetized throughout the experiments, with additional anesthetic being given when required. After the induction of anesthesia, the dorsal skin was shaved, and 1, 3, 10, 30, and 100 mg venom was injected intradermally (100 ml/site in Tyrode solution). The injections were done in a random order using a balanced site pattern. Plasma protein extravasation was measured by the accumulation of i.v. injected 125 I-human serum albumin (2.5mCi/ rat) with Evan's blue dye (25mg/kg; Brain and Williams, 1985) to act as a visual marker. Thirty minutes after venom injection, a blood sample (1 ml) was obtained immediately before the rats were killed with an overdose of anesthetic and the sample then centrifuged (8000g, 10 minutes) to obtain plasma. The injected sites were subsequently punched out and counted for radioactivity, along with the plasma sample, in a gamma counter Marangoni et al., 1993) . Plasma extravasation was expressed as the volume (ml) of plasma accumulated at each skin site compared with the total counts in 1ml plasma.
To evaluate the mechanisms involved in the edema induced by venom (10 mg/site), different drugs were administered, as follows: cyproheptadine (dual serotonin 5-hydroxytryptamine 1/2 and histamine H 1 receptor antagonist; 2 mg/kg, i.p., 30 minutes before; Câmara et al., 2003) , JE 049 (bradykinin B 2 receptor antagonist; 0.6 mg/kg, i.v., 15 minutes before; Costa et al., 2001) , indomethacin (nonselective COX inhibitor; 10 mg/kg, i.p., 1 hour before; Barbosa et al., 2003) , L-NAME (nitric oxide synthase inhibitor; 100 nmol/site, coinjected; Ridger et al., 1997) , mepyramine (histamine H 1 receptor antagonist; 6 mg/kg, i.p., 15 minutes before; Barbosa et al., 2003) , SR140333 (neurokinin NK 1 receptor antagonist; 1 nmol/site, coinjected; Câmara et al., 2003) , and SR48968 (neurokinin NK 2 receptor antagonist; 0.3 mmol/kg, i.v.).
The ability of antiarachnid antivenom to neutralize the edemaforming activity of P. nigriventer, T. serrulatus, and V. dubius venoms was assessed by incubating venom samples with IgG purified from antiarachnidic antivenom by liquid chromatography using a protein G affinity column. After purification, the IgG fraction was lyophilized to allow weighting. The amount of P. nigriventer and T. serrulatus venoms to be injected per site was determined from preliminary experiments using various amounts of venom and found to be 5 mg/site because this produced plasma extravasation similar to that obtained with 10 mg V. dubius venom/site. The IgG concentrations used in the neutralization assays were 0.3 mg/ml for V. dubius venom (1:3, venom:IgG) and 0.1 mg/ml for P. nigriventer and T. serrulatus venoms (1:2, venom:IgG), based on the differential reactivity described by Rocha-e-Silva et al. (2009b) . The mixtures of Igs and venom were preincubated for 1 hour at 37°C before injecting into the dorsal skin.
Rat Hind Paw Edema. Rats were anesthetized with isoflurane, and venom (20 mg/paw) was injected in the subplantar region of the right hind paw. The paw volume was measured immediately before venom injection and 30, 60, 90, 120, and 180 minutes postvenom using a plethysmometer (model 7150; Ugo Basile, Varese, Italy). The volume injected into the paws was always 100 ml. The control group received the same volume of vehicle solution (0.9% NaCl). The increase in paw volume (ml) was calculated as the difference between the basal and final volumes. To evaluate the effect of ketoprofen, a nonselective COX inhibitor, on venom-induced edema, the drug (20 mg/kg, i.p.) was administered 15 minutes after venom or saline (vehicle) injection into the paw. The control group received saline without ketoprofen.
Statistical Analysis. The results are expressed as the mean 6 S.E.M. One-way analysis of variance was used for dorsal skin edema and two-way analysis of variance for hind paw edema, followed by the Tukey test in both cases. A value of P , 0.05 indicated significance. The rats were anesthetized with thiopental, the dorsal skin was shaved, and the animals received an i.v. injection of 125 I-human serum albumin (2.5mCi/rat) with Evan's blue dye (25mg/kg). This was followed by the intradermal injection of vehicle (Tyrode) solution or venom (1-100 mg/site) in a fixed volume (100ml) using a random order and balanced site pattern. Thirty minutes later, the rats were euthanized, the dorsal skin was removed, and the injected sites were punched out and counted in a gamma counter to determine the extent of plasma extravasation (based on the accumulation of radiolabeled albumin). Plasma extravasation was expressed as the volume (ml) of plasma accumulated at each skin site. The columns represent the mean 6 S.E.M. (n = 6). *P , 0.05 compared with vehicle (Tyrode) solution (column with 0 mg venom/site).
Results Figure 1 shows that V. dubius venom caused dose-dependent edema in rat dorsal skin, with the plasma extravasation increasing by nearly 11-fold with the highest dose (from 17 6 1 ml for the Tyrode control to 202 6 10 ml for 100 mg/site); even at this highest dose there was no apparent plateau in the curve. Based on this dose-response curve, a venom dose that produced an intermediate edematogenic response (10 mg/site) was chosen for subsequent experiments. Postmortem examination of the rats used in this protocol revealed no macroscopic alterations or damage to internal organs, including the heart, lungs, kidney, and liver; no microscopic (histologic) analysis of these organs was undertaken.
The potential mediators of the venom-induced edema in rat dorsal skin were investigated using antagonists and doses reported in similar studies in the literature. Mepyramine (a histamine H 1 receptor antagonist) and JE 049 (a bradykinin B 2 receptor antagonist) had no effect on the venom-induced edema. In contrast, cyproheptadine (a dual histamine and serotonin receptor antagonist) abolished the plasma extravasation to the level seen with saline alone (plasma extravasation from 76 6 6 ml with venom to 36 6 8 ml with venom 1 cyproheptadine; n 5 6 each), and indomethacin partially inhibited the edema from 108 6 10 ml with venom alone to 61 6 15 ml with venom plus indomethacin (n 5 6 each) (Fig. 2) . Treatment with L-NAME (a nitric oxide synthase inhibitor) reduced the edema by ∼50% (Fig. 3) . These results indicate that histamine and bradykinin are not involved in venominduced edema, but that serotonin, nitric oxide, and COX products are probably involved.
The involvement of neurokinin receptors was investigated using SR140333 and SR48968, neurokinin NK 1 and NK 2 receptor antagonists, respectively. Treatment with the former antagonist resulted in a ∼43% reduction in edema, whereas the latter antagonist had no effect on the edema (Fig. 3) . This finding indicates a role for tachykinins in venom-induced edema and suggests that this effect is mediated specifically by NK 1 neurokinin receptors.
To increase our understanding of the involvement of COX products in venom-induced edema, we examined the ability of V. dubius venom to cause edema in rat hind paw. This model has an advantage over the dorsal skin model in that it allows time-course curves to be obtained in the same animals. In rat hind paw, V. dubius venom (20 mg/paw) caused marked edema that was maximal at 30 minutes and decreased progressively thereafter over the ensuing 150 minutes (Fig. 4) . Treatment with ketoprofen given 15 minutes postvenom, that is, before the first measurement of edema postvenom, did not significantly affect the peak edematogenic responses (30 minutes postvenom) but significantly hastened the recovery from venom-induced edema at the later postvenom intervals. At 3 hours (180 minutes) postvenom, edema formation in the venom plus ketoprofen group was significantly lower than with venom alone (0.15 6 0.03 ml and 0.30 6 0.05 ml, respectively; n 5 6 each).
P. nigriventer and T. serrulatus venoms (5 mg/site each) produced plasma extravasation that was not significantly different from that caused by V. dubius (10 mg/site), despite the slightly smaller response with P. nigriventer venom. Preincubation with purified antiarachnid IgG in a venom:IgG ratio of 1:2 abolished the edema caused by P. nigriventer and T. serrulatus venoms (positive controls), whereas a venom:IgG ratio of 1:3 only partially and nonsignificantly attenuated the plasma extravasation produced by V. dubius venom (Fig. 5 ).
Discussion
Although bites by theraphosids can produce local effects such as pain, erythema, and edema (Lucas et al., 1994) , few studies have examined the mediators and mechanisms involved in the edema caused by these venoms. As shown in this work, V. dubius venom caused edema in rat dorsal skin and hind paw, with the latter being similar to the rat paw edema reported for venom of the theraphosid Acanthoscurria paulensis; in this species, venom (20-60 mg/paw) produced Fig. 2 . The role of histamine, serotonin, bradykinin, and COX products in V. dubius (Vd) venom-induced plasma extravasation. The rats were prepared and treated as described in the legend for Fig. 1 , except that prior to venom injection they received mepyramine (histamine H 1 receptor antagonist; 6 mg/kg, i.p., 15 minutes before), cyproheptadine (dual serotonin 5-hydroxytryptamine 1/2 and histamine H 1 receptor antagonist; 2 mg/kg, i.p., 30 minutes before), JE 049 (B 2 receptor antagonist; 0.6 mg/kg, i.v., 15 minutes before), or indomethacin (nonselective COX inhibitor; 10 mg/kg, i.p., 1 hour before). Subsequently, vehicle (Tyrode) solution, the respective positive control, and venom (10 mg/site) were injected intradermally in a fixed volume (100ml). Thirty minutes later, the rats were euthanized and processed, as described in Fig. 1 . Plasma extravasation was expressed as the volume (ml) of plasma accumulated at each skin site. Histamine (His, 30 nmol/ site), compound 48/80 (C48/80, 1 mg/site), and bradykinin (BK, 0,1 nmol/site?) were used as positive controls. The columns represent the mean 6 S.E.M. (n = 6). *P , 0.05 compared with vehicle (Tyrode) solution and # P , 0.05 compared with the corresponding response to venom alone.
Vitalius dubius Venom-Induced Edema dose-dependent edema that was significant within 10 minutes postvenom and lasted for at least 2 hours (Mourão et al., 2013) . Edema formation has also been observed for nontheraphosid spiders such as P. nigriventer (Antunes et al., 1992 Bento et al., 1995; Costa et al., 1997) and Loxosceles spp. (Rattmann et al., 2008; Paludo et al., 2009; Barbaro et al., 2010; Guimarães et al., 2013; Ribeiro et al., 2015) , and a variety of Australian spiders (Atkinson, 1986; Korszniak and Story, 1995) . Unlike envenoming by Loxosceles spp. (Futrell, 1992; Tambourgi et al., 2010) , V. dubius venom caused no macroscopic local dermonecrosis; there were also no macroscopic alterations or damage to internal organs. This lack of local and systemic lesions agrees with the absence of proteolytic (caseinolytic, elastolytic, and collagenolytic) activity in this venom (Rocha-e-Silva et al., 2009b) .
To examine the mediators involved in the venom-induced edema, rats were treated with various antagonists before or concomitantly with venom. Histamine contained in the venom or released by mast cell degranulation by venom components could potentially contribute to venom-induced edema. However, as shown in this work, treatment with mepyramine, a histamine H 1 receptor antagonist, had no effect on V. dubius venom-induced edema, indicating no role for this mediator in this response. Although there has been no systematic screening for the presence of histamine in theraphosid venoms, mass spectrometric analysis of venom from Hapopelma lividum indicated only a very low content of histamine (0.14%) in this venom (Moore et al., 2009) . In contrast, histamine is involved in P. nigriventer venom-induced edema in rat skin (Palframan et al., 1996) and hind paw (Costa et al., 2000 (Costa et al., , 2001 following the activation of mast cells. Histamine has a role in the vascular permeability caused by Atrax spp. venoms (Atkinson, 1986 ) but is not a major mediator in edema caused by other Australian spider venoms (Korszniak and Story, 1995) .
In contrast to the lack of involvement of histamine, serotonin was an important mediator of V. dubius venom-induced edema because cyproheptadine (a mixed serotonin/histamine receptor antagonist) significantly attenuated the venominduced edema. Atkinson (1986) reported that the edema caused by Atrax sp. venoms in rats resulted from the degranulation of mast cells in the microcirculation, leading to the release of histamine and serotonin. The use of a mixture of histamine and serotonin antagonists abolished the edema, whereas lesions to the sensory nerve did not affect the edema. Costa et al. (2000) have also noted that the blockade of histamine and serotonin receptors attenuated the edema caused by P. nigriventer venom.
Tachykinins (substance P and neurokinins A and B) exert a variety of functions in the peripheral nervous system, including the modulation of vascular permeability and pain. Substance P acts though NK 1 receptors, whereas neurokinins A and B act through NK 2 receptors. Tachykinins have been implicated in the edema caused by venoms of the spider P. nigriventer (Palframan et al., 1996; Costa et al., 1997 Costa et al., , 2001 ) and the social wasp Polistes lanio lanio (Yshii et al., 2009) , and in itching caused by P. nigriventer venom (Costa et al., 2006) . Because these responses are abolished by blockade of NK 1 but not NK 2 receptors, and attenuated in NK 1 knockout mice, the conclusion is that substance P is the main mediator involved. The activation of NK 1 receptors by P. nigriventer venom is apparently indirect, following the stimulation of sensory nerves to release substance P, rather than through direct stimulation by tachykinin-like peptides in the venom (Costa et al., 1997) . Although tachykinin-like peptides have been identified in the venoms of P. nigriventer (Pimenta et al., 2005) and P. l. lanio (Yshii et al., 2009) , the extent to which they contribute to venom-induced edema is unclear.
Our findings for V. dubius agree with this general pattern regarding a role for NK 1 but not NK 2 receptors in arthropod venom-induced edema. However, our experimental protocol did not allow us to distinguish between direct activation of the receptors by venom peptides or indirect activation through the release of substance P after sensorial nerve stimulation. In contrast to venom-induced edema, the hyperalgesia caused by P. nigriventer venom involves both peripheral and central NK 1 and NK 2 receptors (Zanchet and Cury, 2003; Zanchet et al., 2004) , whereas the venoms of the Trinidad Chevron tarantula (Psalmopoeus cambridgei) (Siemens et al., 2006) and the Chinese bird spider (Ornithoctonus huwena) (Bohlen et al., 2010) contain toxins (vanillotoxins-VaTx1, 2, and 3, and a "double-knot" toxin-DkTx, respectively) that activate capsaicin-sensitive TRPV1 receptors. A role for vanilloid receptor activation in modulating the edema induced by P. nigriventer venom has also been suggested (Costa et al., 2000) .
In contrast to the involvement of tachykinin NK 1 receptors, the lack of effect of JE 049 (Icatibant, HOE-140) , a bradykinin Fig. 3 . Role of nitric oxide and neurokinins in V. dubius (Vd) venominduced plasma extravasation. The rats were prepared and treated as described in the legend for Fig. 1 , except that prior to venom injection they received (Upper panel) L-NAME (nitric oxide synthase inhibitor; 100 nmol/site) and (Lower panel) SR140333 (neurokinin NK 1 receptor antagonist; 1 nmol/site) or SR48968 (neurokinin NK 2 receptor antagonist; 0.3 mmol/kg, i.v.) that were coadministered with venom (10 mg/site) in a fixed volume (100ml). Thirty minutes later, the rats were euthanized and processed as described in Fig. 1 . Plasma extravasation was expressed as the volume (ml) of plasma accumulated at each skin site. The columns represent the mean 6 S.E.M. (n = 6). *P , 0.05 compared with vehicle (Tyrode) solution and # P , 0.05 compared with the corresponding response to venom alone. B 2 receptor antagonist, on the venom-induced edema indicated that kinins were not involved in the edematogenic response to V. dubius venom. Kinins are apparently also not involved in the edema induced by P. nigriventer venom (Costa et al., 2000 (Costa et al., , 2001 . However, in other spider venoms, for example, Scaptocosa raptorial (Ferreira et al., 1998) , kinin-like peptides may be important mediators of venom-induced edema. Kinins are also not involved in the mouse dorsal skin edema caused by P. l. lanio wasp venom (Yshii et al., 2009) .
The ability of L-NAME, a nonselective inhibitor of nitric oxide synthase, to attenuate the venom-induced edema indicated a role for nitric oxide in this response. Nitric oxide production could be stimulated directly by V. dubius venom components, for example, peptides, or indirectly via mediators released by the venom. Endothelium-derived nitric oxide has also been implicated in the vasodilation caused by Lasiodora sp. venom (Horta et al., 2013) .
In addition to the mediators (serotonin, nitric oxide, COX products, and tachykinins/substance P) shown to be involved in V. dubius venom-induced edema, other mediators not examined in this work may also have a role. For example, adenosine 59-diphosphate is the principal mediator of edema caused by venom of the theraphosid Lasiodora sp. (Horta et al., 2013) , whereas adenosine 59-diphosphate and ATP may actually inhibit edema caused by P. nigriventer venom (Costa et al., 2000) .
The finding that the nonselective COX inhibitors indomethacin and ketoprofen significantly attenuated the venominduced edema in rat dorsal skin and hind paw, respectively, indicated an important role for COX products, primarily the vasodilators prostacyclin and prostaglandin E 1 , in this response. The finding for ketoprofen is of practical relevance as it suggests that COX inhibitors may be useful for treating venom-induced edema after theraphosid bites. Whereas the observation that the hind paw edema was significantly attenuated only in its later stages of development may indicate that this is the phase in which COX products are acting, it may also simply reflect the kinetics of ketoprofen absorption and the time required for COX inhibition rather than being an indicator of a lack of involvement of COX products in the early phase of the edema. The ability of COX inhibitors to attenuate arthropod venominduced edema has also been reported for experimental envenoming with P. nigriventer (Zanchet et al., 2004) and T. serrulatus (Nascimento Jr. et al., 2005) venoms.
Antivenom is standard treatment of envenoming by spiders (e.g., P. nigriventer and Loxosceles spp.) (Bucaretchi et al., 2000 (Bucaretchi et al., , 2008 Bucaretchi and Hyslop, 2009 ) and scorpions (Tityus spp.) (Bucaretchi et al., 2014) in Brazil. The finding that the increase in vascular permeability caused by P. nigriventer and T. serrulatus venoms was abolished by antivenom agreed with the demonstration by Toro et al. (2006) that IgG partially neutralized the edematogenic activity of these two venoms and indicated that the venom components responsible for this activity were peptides/polypeptides that were sufficiently immunogenic so as to stimulate antibody production in horses. We have previously shown, using ELISA and immunoblotting, that V. dubius venom also cross-reacts with this antiarachnid antivenom produced by the Instituto Butantan (Rocha-e-Silva et al., 2009b) . Immunoblotting showed that only venom components .10 kDa reacted with the antivenom (Rocha-e-Silva et al., 2009b), including hyaluronidase (45 kDa) (Sutti et al., 2014) . Studies with T. serrulatus scorpion venom have shown that hyaluronidase has an important role in the action of this venom (Pessini et al., 2001; Horta et al., 2014) , and we have also observed the V. dubius enzyme to be edematogenic. However, in contrast to P. nigriventer and T. serrulatus venom-induced edema, the response to V. dubius venom was only partially neutralized by antivenom, perhaps indicating incomplete immunologic identity between the theraphosid venom components responsible for Fig. 4 . Attenuation of V. dubius venom-induced rat hind paw edema by ketoprofen (cyclooxygenase inhibitor; 20 mg/kg, i.p.) administered 15 minutes after venom. Rats were lightly anesthetized with isoflurane for venom injection in the subplantar region of the right hind paw. The paw volume was measured immediately before the injection of venom (20 mg/paw) or 0.9% NaCl (vehicle control) and at various intervals thereafter using a plethysmometer. The volume injected into the paws was always 100 ml. The increase in paw volume (ml) was calculated as the difference between the basal and final volumes. The points represent the mean 6 S.E.M. (n = 6). All time points in the venom + saline and venom + ketoprofen groups were significantly different from the corresponding controls. *P , 0.05 compared with the corresponding times in the venom + saline group. Fig. 5 . Neutralization of V. dubius (Vd, 10 mg/site), P. nigriventer (Pn, 5 mg/ site), and T. serrulatus (Ts, 5 mg/site) venom-induced plasma extravasation by IgG purified from antiarachnid antivenom. The venoms were incubated with IgG purified from antiarachnid antivenom (0.3 mg/ml for V. dubius and 0.1 mg/ml for P. nigriventer and T. serrulatus) for 1 hour at 37°C prior to testing in rat dorsal skin. The venom:IgG ratios used for these neutralization assays were 1:2 for P. nigriventer and T. serrulatus and 1:3 for V. dubius. Plasma extravasation was assessed by injecting venom and venom + antivenom IgG mixtures intradermally in the dorsal skin of anesthetized rats. Thirty minutes later, the rats were euthanized and processed, as described in Fig. 1 . Plasma extravasation was expressed as the volume (ml) of plasma accumulated at each skin site. The columns represent the mean 6 S.E.M. (n = 6). *P , 0.05 compared with vehicle (Tyrode) solution and # P , 0.05 compared with the corresponding response to venom alone.
Vitalius dubius Venom-Induced Edema causing edema and those of P. nigriventer and T. serrulatus venoms used to produce the antivenom, or that V. dubius venom contains peptides/proteins that are not present in the venoms used for antivenom production. Although antiarachnid antivenom partially neutralized the edema-forming activity of V. dubius venom, the mild clinical symptoms associated with bites by most Brazilian theraphosids means that antivenom therapy is unlikely to be used, with treatment being essentially symptomatic. In addition, the risk of the patient developing a hypersensitivity reaction or serum sickness in response to antivenom considerably outweighs the potential clinical benefits of this treatment. In this case, the administration of a nonsteroidal anti-inflammatory drug such as ketoprofen could be a useful alternative.
In conclusion, we have shown that V. dubius venom causes local edema in two rat models, and this edema is dependent on COX products, nitric oxide, serotonin, and tachykinins, but not on histamine or kinins. The attenuation of hind paw edema by ketoprofen suggests that COX inhibitors may be useful for treating the local responses to envenoming by theraphosids in animals and humans.
